| Name | Role | Date | Shares | Price | Value | 
|---|---|---|---|---|---|
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2025-10-24 | 755 | $196.77 | $148.56kSell | 
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2025-10-23 | 495 | $187.16 | $92.64kSell | 
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2025-10-22 | 920 | $186.68 | $171.75kSell | 
| Steven Leonard Chapman | CEO AND PRESIDENT | 2025-10-21 | 1,603 | $187.95 | $301.28kSell | 
| John Fesko | PRESIDENT CHIEF BUS. OFFICER | 2025-10-21 | 339 | $187.95 | $63.72kSell | 
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2025-10-21 | 464 | $187.95 | $87.21kSell | 
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-10-21 | 292 | $187.95 | $54.88kSell | 
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2025-10-21 | 602 | $187.95 | $113.15kSell | 
| Jonathan Sheena | Director | 2025-10-21 | 93 | $187.95 | $17.48kSell | 
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2025-10-20 | 10,000 | $190.00 | $1.90MSell | 
| Name | Hold | Shares | Value | Type | 
|---|---|---|---|---|
| Vanguard Group Inc | 9.28% | 12,676,653 | $2.40B | Institution | 
| Price T Rowe Associates Inc | 8.93% | 12,187,816 | $2.31B | Institution | 
| Blackrock Inc | 8.02% | 10,956,715 | $2.08B | Institution | 
| Jpmorgan Chase Co | 7.78% | 10,625,785 | $2.01B | Institution | 
| Claremont Creek Ventures L P | 4.29% | 5,864,630 | $1.11B | Insider | 
| Roelof Botha | 4.16% | 5,683,920 | $1.08B | Insider | 
| Sc XII Management LLC | 3.97% | 5,421,122 | $1.03B | Insider | 
| Matthew Rabinowitz | 3.55% | 4,849,420 | $919.30M | Insider | 
| Farallon Capital Management LLC | 3.53% | 4,821,809 | $914.07M | Institution | 
| James Healy | 3.44% | 4,697,100 | $890.43M | Insider |